Shuqiang Liu
Overview
Explore the profile of Shuqiang Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
568
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou J, Hu D, Feng N, Liu S, Li J
Animals (Basel)
. 2025 Jan;
14(24.
PMID: 39765609
The adult male muskrat has a pair of scented glands, which show clear seasonal changes in their developmental status between the secretion season and non-secretion season. During the secretion season,...
2.
Tan C, Wu D, Yang X, Zhang S, Liu S, Yu B, et al.
Heliyon
. 2025 Jan;
11(1):e41180.
PMID: 39758401
Background: TOX is a transcription factor that is implicated in the regulation of T cell exhaustion in tumors. TOX has been proven to have prognostic value in some malignant tumors....
3.
Tan C, Xu J, Yang X, Wu D, Zhang S, Liu S, et al.
Int J Med Sci
. 2024 Nov;
21(14):2640-2654.
PMID: 39512692
The aim of this research is to investigate whether the GRIm score serves as a novel prognostic tool for predicting the survival rates among early breast cancer patients undergoing surgical...
4.
Tan C, Xu J, Zhang S, Liu S, Yang X, Wu D, et al.
Breast Cancer (Dove Med Press)
. 2024 Oct;
16:705-723.
PMID: 39464238
Purpose: The current investigation is to assess FOXP3 expression in breast cancer patients and evaluate the predictive significance of FOXP3. Patients And Methods: A cohort of 313 cases between January...
5.
Liu S, Jiang C, Wu D, Zhang S, Qiao K, Yang X, et al.
BMC Womens Health
. 2024 Oct;
24(1):560.
PMID: 39395992
Background: Achieving a pathological complete response (pCR) after neoadjuvant therapy (NAT) is considered to be a critical factor for a favourable prognosis in breast cancer. However, discordant pathological complete response...
6.
Wang Y, Yang P, Chen T, Hu J, An X, Yao C, et al.
Sci Rep
. 2024 Jul;
14(1):16980.
PMID: 39043795
Musk is an important animal product, but the musk secretion mechanism of forest musk deer (Moschus berezovskii) is still unclear. The musk synthesis process in forest musk deer is extremely...
7.
Zhao X, Wang Y, Xia H, Liu S, Huang Z, He R, et al.
J Clin Transl Hepatol
. 2023 Aug;
11(5):1170-1183.
PMID: 37577231
Hepatocellular carcinoma (HCC) being a leading cause of cancer-related death, has high associated mortality and recurrence rates. It has been of great necessity and urgency to find effective HCC diagnosis...
8.
Zhou Z, Wang Y, Liu S, Phillis A, Zhang Q, Ye W
J Vis Exp
. 2023 Feb;
(192).
PMID: 36847402
The demand for aromatic fluorides is steadily increasing in the pharmaceutical and fine chemical industries. The Balz-Schiemann reaction is a straightforward strategy for preparing aryl fluorides from aryl amines, via...
9.
Liu F, Zhang Z, Liu S, Feng Z
PLoS One
. 2022 Dec;
17(12):e0279621.
PMID: 36548308
Background: Mainland China has the most smartphone users worldwide, especially among college students, while mindfulness intervention can significantly alleviate the level of problematic smartphone use. We examined the effects of...
10.
Luo K, Liu S, Shen X, Xu J, Shi C, Chao Y, et al.
Front Cell Dev Biol
. 2022 Dec;
10:1003656.
PMID: 36467413
Anti-programmed cell death 1/programmed cell death ligand 1 (PD1/PDL1) therapy is an important part of comprehensive cancer therapy. However, many patients suffer from non-response to therapy. Tumor neoantigen burden (TNB)...